Hunan Fangsheng Pharmaceutical Co., Ltd. (SHA:603998)
China · Delayed Price · Currency is CNY 10.82
-0.20 (-1.81%)
Apr 9, 2026, 3:00 PM CST
SHA:603998 Market Cap
SHA:603998 has a market cap or net worth of 4.75 billion as of April 9, 2026. Its market cap has increased by 13.77% in one year.
Market Cap
4.75B
Enterprise Value
5.14B
Revenue
1.68B
Ranking
n/a
PE Ratio
16.15
Stock Price
10.82
Market Cap Chart
Since January 7, 2015, SHA:603998's market cap has increased from 2.80B to 4.75B, an increase of 69.40%. That is a compound annual growth rate of 4.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 4.75B | -3.74% |
| Dec 31, 2025 | 4.94B | 7.86% |
| Dec 31, 2024 | 4.58B | -5.06% |
| Dec 29, 2023 | 4.82B | 36.87% |
| Dec 30, 2022 | 3.52B | 20.58% |
| Dec 31, 2021 | 2.92B | 13.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jinling Pharmaceutical Company | 5.04B |
| Bide Pharmatech | 5.01B |
| Tibet Duo Rui Pharmaceutical | 4.92B |
| Zhuhai Rundu Pharmaceutical | 4.86B |
| Newland Pharmaceutical | 4.80B |
| Shandong Sinobioway Biomedicine | 4.74B |
| Yabao Pharmaceutical Group | 4.71B |
| Tibet Weixinkang Medicine | 4.67B |